Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4 + T Cells in Multiple Sclerosis

Journal of Immunology

Volumn 172, Issue 6, 2004, Pages 3893-3904

  Bielekova, Bibiana ^a   Sung, Myong Hee ^b   Kadom, Nadja ^a   Simon, Richard ^b   McFarland, Henry ^a   Martin, Roland ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; HEMAGGLUTININ; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN;

ADULT; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; THYMUS;

EID: 1542723658     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.6.3893     Document Type: Article

References (51)

1. McFarlin, D. E., and H. F. McFarland. 1982. Multiple sclerosis: Part 1. N. Engl. J. Med. 307:1183.
2. Bielekova, B., and R. Martin. 1999. Multiple sclerosis: immunotherapy. Curr. Treatment Options Neurol. 1:201.
3. Burns, J., A. Rosenzweig, B. Zweiman, and R. P. Lisak. 1983. Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell. Immunol. 81:435.
4. Chou, Y. K., M. Vainiene, R. Whitham, D. Bourdette, C. Chou, G. Hashim, H. Offner, and A. A. Vandenbark. 1989. Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA-class II restriction molecules. J. Neurol. Sci. 23:207.
5. Martin, R., D. Jaraquemada, M. Flerlage, J. Richert, J. Whitaker, E. O. Long, D. E. McFarlin, and H. F. McFarland. 1990. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145:540.
6. Pette, M., K. Fujita, B. Kitze, J. N. Whitaker, E. Albert, L. Kappos, and H. Wekerle. 1990. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology 40:1770.
7. Ota, K., M. Matsui, E. L. Milford, G. A. Mackin, H. L. Weiner, and D. A. Hafler. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183.
8. Muraro, P. A., M. Vergelli, M. Kalbus, D. E. Banks, J. W. Nagle, L. R. Tranquill, G. T. Nepom, W. E. Biddison, H. F. McFarland, and R. Martin. 1997. Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire. J. Clin. Invest. 100:339.
9. Allegretta, M., J. A. Nicklas, S. Sriram, and R. J. Albertini. 1990. T Cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247:718.
10. Burns, J., B. Bartholomew, and S. Lobo. 1999. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis. Ann. Neurol. 45:33.
11. Lovett-Racke, A. E., J. L. Trotter, J. Lauber, P. J. Perrin, C. H. June, and M. K. Racke. 1998. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients: a marker for activated/memory T cells. J. Clin. Invest. 101:725.
12. Scholz, C., K. T. Patton, D. E. Anderson, G. J. Freeman, and D. A. Hafler. 1998. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J. Immunol. 160:1532.
13. Harrington, C. J., A. Paez, T. Hunkapiller, V. Mannikko, T. Brabb, M. Ahearn, C. Beeson, and J. Goverman. 1998. Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity 8:571.
14. Targoni, O. S., and P. V. Lehmann. 1998. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187:2055.
15. Ridgway, W. M., and C. G. Fathman. 1999. MHC structure and autoimmune T cell repertoire development. Curr. Opin. Immunol. 11:638.
16. Vanderlugt, C. L., K. L. Neville, K. M. Nikcevich, T. N. Eagar, J. A. Bluestone, and S. D. Miller. 2000. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J. Immunol. 164:670.
17. + T cells directed to self-antigens. Eur. J. Immunol. 33:1409.
18. + T cell responses in vivo and in vitro. Proc. Natl. Acad. Sci. USA 96:9781.
19. Savage, P. A., J. J. Boniface, and M. M. Davis. 1999. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 10:485.
20. Mazzanti, B., B. Hemmer, E. Traggiai, C. Ballerini, H. F. McFarland, L. Massacesi, R. Martin, and M. Vergelli. 2000. Decrypting the spectrum of antigen-specific T-cell responses: the avidity repertoire of MBP-specific T-cells. J. Neurosci. Res. 59:86.
21. Seamons, A., J. Sutton, D. Bai, E. Baird, N. Bonn, B. F. Kafsack, J. Shabanowitz, D. F. Hunt, C. Beeson, and J. Goverman. 2003. Competition between two MHC binding registers in a single peptide processed from myelin basic protein influences tolerance and susceptibility to autoimmunity. J. Exp. Med. 197:1391.
22. Bielekova, B., B. Goodwin, N. Richert, I. Cortese, T. Kondo, G. Afshar, B. Gran, J. Eaton, J. Antel, J. A. Frank, H. F. McFarland, and R. Martin. 2000. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat. Med. 6:1167.
23. Muraro, P. A., K. P. Wandinger, B. Bielekova, B. Gran, A. Marques, U. Utz, H. F. McFarland, S. Jacobson, and R. Martin. 2003. Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders. Brain 126:20.
24. Martin, R., B. Bielekova, B. Gran, and H. F. McFarland. 2000. Lessons from studies of antigen-specific T cell responses in multiple sclerosis. J. Neural Transm. Suppl. 60:361.
25. McDonald, W. I., A. Compston, G. Edan, D. Goodkin, H. P. Hartung, F. D. Lublin, H. F. McFarland, D. W. Paty, C. H. Polman, S. C. Reingold, et al. 2001. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50:121.
26. Houghten, R. A. 1985. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 82:5131.
27. Bielekova, B., P. A. Muraro, L. Golestaneh, J. Pascal, H. F. McFarland, and R. Martin. 1999. Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7. J. Neuroimmunol. 100:115.
28. + subsets differ with respect to epitope specificity and functional antigen avidity. J. Immunol. 164:5474.
29. Brenchley, J. M., D. C. Douek, D. R. Ambrozak, M. Chatterji, M. R. Betts, L. S. Davis, and R. A. Koup. 2002. Expansion of activated human naive T-cells precedes effector function. Clin. Exp. Immunol. 130:432.
30. Jacobsen, M., D. Schweer, A. Ziegler, R. Gaber, S. Schock, R. Schwinzer, K. Wonigeit, R. B. Lindert, O. Kantarci, J. Schaefer-Klein, et al. 2000. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat. Genet. 26:495.
31. Sung, M.-H., and Simon, R. 2003. Candidate epitope identification using peptide property models: application to cancer immunotherapy. Methods on Bioinformatics in Vaccine Design. In press.
32. DeCarli, C., J. Maisog, D. G. Murphy, D. Teichberg, S. I. Rapoport, and B. Horwitz. 1992. Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. J. Comput. Assist. Tomogr. 16:274.
33. + T-cell recognition of influenza A virus hemagglutinin after subunit vaccination. J. Virol. 70:4787.
34. Valli, A., A. Sette, L. Kappos, C. Oseroff, J. Sidney, G. Miescher, M. Hochberger, E. D. Albert, and L. Adorini. 1993. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J. Clin. Invest. 91:616.
35. Baxevanis, C. N., G. J. Reclos, C. Servis, E. Anastasopoulos, P. Arsenis, A. Katsiyiannis, N. Matikas, J. D. Lambris, and M. Papamichail. 1989. Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosis. J. Neuroimmunol. 22:23.
36. Trotter, J. L., W. F. Hickey, R. C. van der Veen, and L. Sulze. 1991. Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides. J. Neuroimmunol. 33:55.
37. Salvetti, M., G. Ristori, M. D'Amato, c. Buttinelli, M. Falcone, C. Fieschi, H. Wekerle, and C. Possilli. 1993. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis. Eur. J. Immunol. 23:1232.
38. Ristori, G., M. Salvetti, C. Buttinelli, M. Falcone, S. Trabace, and C. Fieschi. 1993. Target epitopes of myelin basic protein specific T cell lines in multiple sclerosis. Ital. J. Neurol. Sci. 14:139.
39. + T cells from multiple sclerosis. J. Neuroimmunol. 46:33.
40. Linington, C., T. Berger, L. Perry, S. Weerth, D. Hinze-Setch, Y. Zhang, H.-c. Lu, H. Lassmann, and H. Wekerle. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23:1364.
41. Zhang, J., S. Markovic-Plese, B. Lacet, J. Raus, H. L. Weiner, and D. A. Hafler. 1994. Increased frequency of interleukin-2-responsive T cells specific for myelin basic protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:973.
42. Markovic-Plese, S., H. Fukaura, J. Zhang, A. al-Sabbagh, S. Southwood. A. Sette, v. K. Kuchroo, and D. A. Hafler. 1995. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155: 982.
43. Anderton, S. M., C. G. Radu, P. A. Lowrey, E. S. Ward, and D. C. Wraith. 2001. Negative selection during the peripheral immune response to antigen. J. Exp. Med. 193:1.
44. κ class II molecule. Immunol. Rev. 172:209.
45. Unanue, E. R. 2002. Perspective on antigen processing and presentation. Immunol. Rev. 185:86.
46. Ridgway, W. M., M. Fasso, and C. G. Fathman. 1999. A new look at MHC and autoimmune disease. Science 284:749.
47. + T cell response to a model antigen. J. Immunol. 169:1.
48. Peterson, D. A., R. J. DiPaolo, O. Kanagawa, and E. R. Unanue. 1999. Quantitative analysis of the T cell repertoire that escapes negative selection. Immunity 11:453.
49. Pu, Z., J. A. Carrero, and E. R. Unanue. 2002. Distinct recognition by two subsets of T cells of an MHC class II-peptide complex. Proc. Natl. Acad. Sci. USA 99:8844.
50. Banik, N. L. 1992. Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes. Crit. Rev. Neurobiol. 6:257.
51. Muraro, P., M. Kalbus, G. Afshar, H. McFarland, and R. Martin. 2002. T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients. J. Neuroimmunol. 130:233.